Struggling to use your Frequent Flyer Points?
Frequent Flyer Concierge takes the hard work out of finding award availability and redeeming your frequent flyer or credit card points for flights.
Using their expert knowledge and specialised tools, the Frequent Flyer Concierge team at Frequent Flyer Concierge will help you book a great trip that maximises the value for your points.
No I quoted and said the 5th feb was permission for other public health labs-they are not private labs.I also said it was Feb 29th that CDC authorised private labs to begin testing.Yes things are belatedly changing now. I know you quoted 5 Feb as the date that permission was given, but 29 Feb seems to be the date that is being reported as when private labs could use or create their own testing kits.
Controversies over the lack of diagnostic testing for the COVID-19 virus have dominated U.S headlines for weeks. Technical challenges with the first test developed by the Centers for Disease Control and Prevention (CDC) left the nation with minimal diagnostic capacity during the first few weeks of the epidemic, according to a new paper published today in the Journal of the American Medical Association by Michelle Mello, a professor of medicine at Stanford Health Policy and professor of law at Stanford Law School.
On February 29, the Food and Drug Administration (FDA) began allowing high-complexity labs across the country to use tests they developed in-house. On March 5, the Stanford Clinical Virology Lab deployed its own test for patients at Stanford Health Care and Stanford Children’s Health.
Stanford Law’s Michelle Mello on the Federal Rollout of Diagnostic Testing for the COVID-19 Virus | Stanford Law School
Controversies over the lack of diagnostic testing for the COVID-19 virus have dominated U.S headlines for weeks. Technical challenges with the first tlaw.stanford.edu
Conclusion
Diagnostic testing is critical to an effective response to the novel coronavirus. As the US moves to make up for initial missteps, emerging evidence should guide policy and practice. The public health and medical communities should recognize the need to alter policy to fit changing circumstances and support consistent and compassionate messaging that recognizes both the benefits and limitations of testing.
Diagnostic Testing for the Novel Coronavirus
This Viewpoint explains the technical and regulatory challenges that hampered diagnostic testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the early spread of infection in the US and considers the unintended consequences of making testing more widely available,...jamanetwork.com
On Feb. 29, the Food and Drug Administration announced that it was relaxing the restrictions for the use of diagnostic tests for SARS-CoV-2 developed by laboratories in the United States that meet the certification guidelines for high-complexity testing. The new policy allows these laboratories to begin using in-house developed clinical tests for the virus before obtaining the agency’s approval through an emergency use authorization. The FDA noted that “Rapid detection of COVID-19 cases in the United States requires wide availability of diagnostic testing to control the emergence of this rapidly spreading, severe illness.” Laboratories developing their own tests are expected to apply for emergency use authorization from the FDA within 15 days.
Stanford Medicine COVID-19 test now in use
The Stanford Clinical Virology Laboratory has deployed an in-house diagnostic test for the virus that causes COVID-19. Rapid identification of infected people could help limit the spread of the virus.med.stanford.edu
Part of the issue, the report said, is faulty COVID-19 testing kits issued to states by the CDC in early February. The kits were found to have "faulty negative controls," meaning the results of some test kits were inaccurate, and states had to continue sending test samples to the CDC for testing.
FDA policy prohibited states and private entities from developing their own test kits, meaning they only had access to the faulty FDA kits. The agency lifted that regulation on February 29, allowing states and commercial labs to create their own coronavirus testing kits.
The US government has completed fewer than 6,000 coronavirus tests as more states report new cases and deaths
"We don't have enough tests today to meet what we anticipate will be the demand going forward," Vice President Mike Pence said on Thursday.www.businessinsider.com
FDA approves new coronavirus test that could speed rate of testing up to tenfold | TechCrunch
The U.S. Food and Drug Administration has granted emergency approval for use of a new test that can increase the rate of testing patients by up to 10techcrunch.com
It relied on the same technology as one authorised by the World Health Organisation (WHO) and deployed around the world — except that a fault meant the CDC kit was returning inconclusive results.After testing delays, US COVID-19 cases surge past 900
The number of US cases of the novel coronavirus surged to more than 900, after public health experts criticised authorities for downplaying the epidemic and lagging behind in testing efforts.telanganatoday.com
It was not until February 29, the date of the first US death and more than a month after the first confirmed US case, that the Food and Drug Administration lifted a ban on state laboratories developing their own kits based on the WHO’s tests.
“Adopting broader testing criteria and allowing use of a wider range of tests would have been helpful in identifying the first US cases and containing the spread,” said Michelle Mello of Stanford, a co-author of the JAMA report.
Some relief there:
Some relief there:
The International Air Transport Association (IATA) welcomed the announcement by the European Commission (EC) granting the temporary suspension until June 2020 of the 80-20 “use it or lose it” rule for airport slots.
IATA Welcomes EU Suspension of Slot Use Rules
The International Air Transport Association (IATA) welcomed the announcement by the European Commission (EC) granting the temporary suspension until June 2020 of the 80-20 “use...www.aviationpros.com
Have they named these TA’s yet?
www.france24.com
According to?
Also CX in the mix.Being quoted across multiple sites. It is not guessing
Travel Agents Asked to Put Hold on Ticket Sales From Nine Different Airlines
No tickets can be sold or issued until further noticewww.travelpulse.com
Sample AFF with no advertisements? More..
